CJC-1295-IPA (Without DAC) 5mg + 5mg

CJC-1295 (Without DAC) + Ipamorelin Blend 5mg + 5mg (Lyophilized Powder) For Research Use Only

CJC-1295-IPA is a research blend combining CJC-1295 (without DAC) and Ipamorelin, representing one of the most widely studied GHRH + GHRP combinations for investigating synergistic growth hormone release.

Research suggests this combination may produce amplified and pulsatile GH secretion through simultaneous GHRH receptor activation and ghrelin receptor agonism, with a favorable safety profile for endocrine research.

Product Details:

• Peptides: CJC-1295 Without DAC (5mg) + Ipamorelin (5mg)

• Purity: >98% each

• Form: Lyophilized powder blend

• Quantity: 10mg total (5mg + 5mg) per vial

• Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36°F (2–8°C) and use within 30 days.

• Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.

Potential Research Applications:

• Synergistic GHRH + GHRP GH secretion studies

• GH axis amplification research models

• IGF-1 elevation and anabolic signaling investigations

• Body composition and recovery biology research

For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.